OncoVITA
  1. Companies
  2. OncoVITA
  3. Products
  4. Immuno-Oncolytic Viruses

Immuno-Oncolytic Viruses

SHARE

Engineered viruses have proven to be powerful “bullets” to target cancer cells and to promote their immunogenic death. Oncolytic viruses are replicative viruses that preferentially infect tumor cells while preserving healthy cells. Some of them, in particular the measles virus, exhibit immuno-adjuvant properties that reinforce the antitumor immune response by breaking immune tolerance to the cancer.

Most popular related searches

The potential advantages of oncovirotherapy over conventional cancer treatments include:

  • higher on-target specificity against cancer allowing a better safety margin
  • bypassing resistance to cell death induction in aggressive cancers
  • long-lasting effects due to immune memory activation to prevent relapse and metastasis